ImmunoGen Announces Virtual 2020 Annual Meeting of Shareholders
June 03 2020 - 8:00AM
Business Wire
ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field
of antibody-drug conjugates (ADCs) for the treatment of cancer,
announced today that the 2020 Annual Meeting of Shareholders (the
“Annual Meeting”) will be held virtually due to the public health
impact of the coronavirus outbreak (COVID-19) and to support the
health and well-being of the Company’s management, shareholders,
and other meeting participants.
The Annual Meeting will be held on Wednesday, June 17, 2020 at
9:00 a.m. Eastern in a virtual format only. As described in the
proxy materials for the Annual Meeting previously distributed,
shareholders as of the close of business on April 13, 2020, the
record date, are entitled to participate in the Annual Meeting.
Shareholders who attend the virtual Annual Meeting by following the
instructions below will have an opportunity to vote and to submit
questions electronically during the meeting.
Shareholders will not be able to attend the Annual Meeting in
person. Instead, shareholders can attend the Annual Meeting by
accessing the meeting center at
www.virtualshareholdermeeting.com/IMGN2020.
- Shareholders of Record: Shareholders of record at the close of
business on April 13, 2020 (i.e., shares are held in the
shareholder’s own name in the records of the Company’s transfer
agent, Broadridge Corporate Issuer Solutions, Inc. (“Broadridge”))
can attend the virtual Annual Meeting by accessing the meeting
center at www.virtualshareholdermeeting.com/IMGN2020 and entering
the 16-digit control number on the proxy card or Notice Regarding
the Availability of Proxy Materials previously received.
Shareholders of record that have misplaced their control number can
call Broadridge at (855) 697-4961.
- Beneficial Owners: Beneficial owners of the Company’s common
stock at the close of business on April 13, 2020 (i.e., shares are
held by the shareholder’s broker in “street name”) can attend the
Annual Meeting by accessing the meeting center at
www.virtualshareholdermeeting.com/IMGN2020 and entering the
16-digit control number found on the notice and instructions
received from their broker or other nominee.
If a shareholder does not have their 16-digit control number,
the shareholder will be able to access and listen to the Annual
Meeting as a guest, but the shareholder will not be able to vote
their shares or submit questions during the Annual Meeting.
Instructions on how to connect to the Annual Meeting and
participate via the Internet, including how to demonstrate proof of
stock ownership, ask questions, and vote, are posted at
www.virtualshareholdermeeting.com/IMGN2020.
Shareholders will also be able to submit questions through the
platform being used for the Annual Meeting. Shareholders may ask
questions that are confined to matters properly presented at the
Annual Meeting and of general concern to the Company.
The Annual Meeting will begin promptly at 9:00 a.m. Eastern on
June 17, 2020. Shareholders are encouraged to access the Annual
Meeting prior to the start time. Online access will open
approximately at 8:45 a.m. Eastern, and shareholders should allow
ample time to log in to the Annual Meeting and test their computer
audio system. The Company recommends that shareholders carefully
review in advance the procedures needed to gain admission to the
Annual Meeting.
Whether or not a shareholder plans to attend the Annual Meeting,
the Company urges shareholders to vote and submit their proxy in
advance of the Annual Meeting by one of the methods described in
the proxy materials for the Annual Meeting.
A notice regarding this change to a virtual meeting format (the
“Notice”) is being filed with the Securities and Exchange
Commission together with this press release. Additional information
regarding the Annual Meeting, shareholder participation and voting
is provided in the Notice, which all shareholders are urged to
read.
Technical Difficulties
If shareholders encounter any difficulties accessing the virtual
meeting during the check-in or meeting time, please call the
technical support number that will be posted on the virtual Annual
Meeting log in page.
The virtual Annual Meeting platform is fully supported across
browsers (Internet Explorer, Firefox, Chrome, and Safari) and
devices (desktops, laptops, tablets, and cell phones) running the
most updated version of applicable software and plugins.
Shareholders should ensure that they have a strong internet
connection wherever they intend to participate in the Annual
Meeting. Shareholders should also give themselves plenty of time to
log in and ensure that they can hear streaming audio prior to the
start of the Annual Meeting.
ABOUT IMMUNOGEN
ImmunoGen is developing the next generation of antibody-drug
conjugates (ADCs) to improve outcomes for cancer patients. By
generating targeted therapies with enhanced anti-tumor activity and
favorable tolerability profiles, we aim to disrupt the progression
of cancer and offer our patients more good days. We call this our
commitment to “target a better now.”
Learn more about who we are, what we do, and how we do it at
www.immunogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200603005205/en/
INVESTOR RELATIONS AND MEDIA ImmunoGen Courtney O’Konek
781-895-0600 courtney.okonek@immunogen.com
OR
FTI Consulting Robert Stanislaro 212-850-5657
robert.stanislaro@fticonsulting.com
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Sep 2023 to Sep 2024